Taxonomic study uncovers a new frog species of genus Niceforonia in Colombian cloud forests, highlighting a shared phenotypic synapomorphy within Strabomantidae.
A new species of Niceforonia is described from the montane cloud forests of southwestern Colombia. The new species is distinguished from all congeners by possessing dorsolateral folds, a visible tympanic membrane, a fleshy lip swelling in adult males, nuptial pads, circumferential grooves on all fingers, a reddish-brown to grayish dorsal coloration, yellow ventral and hidden surfaces, and dark supra-inguinal spots. Molecularly, the new species differs from all congeners by an uncorrected p -distance of > 7% for the 16S rRNA gene fragment. Furthermore, the possession of dark supra-inguinal spots optimizes unambiguously as a synapomorphy for two clades within Strabomantidae. The first clade comprises members of the genus Niceforonia and includes N. brunnea , N. dracula , N. elassodiscus , N. mantipus , N. nigrovittata , N. quilloturo , N. peraccai , four candidate species, and the new species described herein. This clade is referred to as the Niceforonia nigrovittata species group, diagnosed by the presence of dark supra-inguinal spots. By retaining this name, we ensure taxonomic stability and honor the well-established historical use of the nomenclature in literature. The second clade comprises members of the subfamily Holoadeninae, including the genera Bahius , Barycholos , Phyllonastes , and Urkuphryne . A previous study already proposed a phenotypic synapomorphy for the group composed of Phyllonastes + Barycholos . Consequently, the available evidence corroborates the monophyly of both the group comprising these four holoadenine genera and the Phyllonastes + Barycholos group. This congruence provides a robust, nested phylogenetic resolution and precise taxonomic diagnoses, demonstrating how the integration of molecular and phenotypic evidence is a powerful tool for testing evolutionary hypotheses in brachycephaloid frogs.
No takes yet. Share an insight, caveat, or question.
Ospina‐Sarria et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: